Miotine
![]() | |
| Names | |
|---|---|
| IUPAC name [3-[1-(Dimethylamino)ethyl]phenyl] N-methylcarbamate | |
| Other names | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider | |
| KEGG | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C12H18N2O2 | |
| Molar mass | 222.288 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Miotine is an anticholinesterase drug. Miotine was the first synthetic carbamate that was used clinically.[2]
Unlike the miotine analog neostigmine, it doesn't have a quaternary ammonium group to give it a permanent positive charge. It can exist as an uncharged free base which could allow it to cross the blood–brain barrier and cause unwanted central nervous system (CNS) side effects.[3]

Miotine equilibrium
See also
References
- ^ a b Chemical Warfare Agents, and Related Chemical Problems. Parts I-II. 1958.
- ^ "Archived copy" (PDF). Archived from the original (PDF) on 2009-05-09. Retrieved 2008-01-04.
{{cite web}}: CS1 maint: archived copy as title (link) - ^ "An introduction to drugs,their action and discovery" (PDF).
